US OptionsDetailed Quotes

AER240517C65000

Watchlist

0.00
0.000.00%

15min DelayClose May 17 09:30 ET

0.00High0.00Low

AerCap Holdings Stock Discussion

Moomoo AI

Jan 25 01:58

Despite trading below the industry PE ratio, the prospect of negative growth poses some risk. Investors should further research the stock and consider future risks associated with negative growth prospects.

What Does AerCap Holdings N.V.'s (NYSE:AER) Share Price Indicate?

Moomoo AI

Dec 29, 2023 19:08

Investor optimism over AerCap Holdings' revenue performance may raise the P/S ratio. However, failing to match growth outlooks could disappoint shareholders. The company may struggle to maintain share prices without short-term industry outperformance.

AerCap Holdings N.V.'s (NYSE:AER) Share Price Not Quite Adding Up

Moomoo AI

Nov 14, 2023 18:08

AerCap's acquisition of GE90 engines from Sanad underscores a strong leasing sector demand. Building relations with major industry players like Sanad could offer AerCap strategic benefits in portfolio growth and future partnerships.

Press Release: AerCap Acquires Five General Electric GE90 Engines From Sanad

Moomoo AI

Oct 11, 2023 21:34

AerCap Holdings' low ROE and high debt usage is of concern, particularly given shifting credit markets. High returns despite significant debt are favourable, but it may backfire if borrowing gets harder.

Can AerCap Holdings N.V. (NYSE:AER) Improve Its Returns?

Mooers Radar

Sep 13, 2023 08:29

ColumnsUS Top Gap Ups and Downs on 9/12: ORCL, PKX, CASY, NBIX and More

Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Caseys General Stores(CASY.US)$ - up 4.9%
2. $Neurocrine Biosciences(NBIX.US)$ - up 3.4%
3. $Grifols(GRFS.US)$ - up 2.4%
4. $Stellantis NV(STLA.US)$ - up 1.1%
5. $Takeda Pharmaceutical(TAK.US)$ - up 1.1%
6. $Novartis AG(NVS.US)$ - up 0.8%
7. $Vodafone(VOD.US)$ - up 0.7%
8. $Zions Bancorp(ZION.US)$ - up 0.6...

+13

MACKGforEver

May 16, 2023 16:01

Billionaire George Soros Loads Up on These 2 ‘Strong Buy’ Stocks

If you’re going to be forever known for one thing, being the ‘man who broke the Bank of England’ is a description many would sign up for. That is how George Soros is regularly introduced, and the story involves how he bet against the British Pound in 1992 and pocketed $1 billion from the trade in a single day.
Of course, Soros’ legendary reputation does not rest solely on that headline-grabbing act, and the billionaire investor has ...

Unlock the trends of smart money: The Power of 13F Filings

Analysts Notebook

May 15, 2023 21:17

ColumnsUS Top Rating Updates on 5/15: META, GOOG, ESS, FDS and More

Loop Capital Upgrades $Meta Platforms(META.US)$ to Buy, Raises Price Target to $320
Loop Capital analyst Rob Sanderson upgrades Meta Platforms from Hold to Buy and raises the price target from $220 to $320.
Loop Capital Downgrades $Alphabet-C(GOOG.US)$ to Hold, Announces $125 Price Target
Loop Capital analyst Rob Sanderson downgrades Alphabet from Buy to Hold and announces $125 price target.
$FactSet Research Systems(FDS.US)$ Receive...

Analysts Notebook

Oct 8, 2022 18:18

ColumnsAirlines Enter Earnings Season Wrestling With Challenges: What to Expect？

The airline industry is still dealing with issues that have plagued it all year, according to Cowen analyst Helane Becker. These include volatile jet fuel prices, supply chain issues causing delays in maintenance and repair, aircraft delivery delays and difficulty hiring and retaining employees, particularly pilots.
We will also be looking for companies to talk about their plans to rein in costs. We are well aware salaries ...

Moomoo Breakfast US

Mar 30, 2022 20:35

ColumnsToday's pre-market stock movers: ADGI, LULU, CHWY, MVST and more

Gainers
• $MillerKnoll(MLKN.US)$ +12.4%, $BioNTech(BNTX.US)$ +7.4%, $Lululemon Athletica(LULU.US)$ +6.5% (also authorizes $1 bln stock repurchase program)
• $Adagio Therapeutics(ADGI.US)$ +52.47% (announces ADG20 (adintrevimab) is the first monoclonal antibody to meet primary endpoints with statistical significance across pre- and post-exposure prophylaxis and treatment for COVID-19 and plans to seek US emergency use authorization)
...

Ashish Barman

Nov 16, 2021 08:08

GE breakup plan sets stage for P-E 'feeding frenzy' for assets

$GE Aerospace(GE.US)$'s decision to split into three companies has private-equity firms looking to carve up GE into even more pieces, the Financial Times reports.
"We are sharpening the pencils," one executive at a large, global alternative asset manager tells FT, who sees everything other than healthcare potentially selling off for a better price in the private marketplace than when it goes public.
GE's energy unit could be sold piecemeal, with RBC analyst Deane Dray telling FT that "any business in the power portfolio is considered non-core. Those would be perfect candidates for private equity."
The unit carries low margins and is forecast by analysts at CreditSights to generate just $1.3B in combined operating cash flow this year across a "hodgepodge of detached businesses."
Other areas of opportunity for alternative asset management giants such as $Apollo Global Management(APO.US)$. $Blackstone(BX.US)$ , $Brookfield Asset Management(BAM.US)$, $The Carlyle Group(CG.US)$ and KKR are said to include GE's 45% stake in $AerCap Holdings(AER.US)$ and the troubled long-term care insurance business.
"This is epochal," a P-E partner tells FT, calling GE's break-up the "death knell" of the conglomerate business strategy.
Dray's sum-of-the-parts model points to an implied valuation of ~$130/share.

No comment yet